- Not Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
I am a Consultant Thoracic Medical Oncologist at The Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research. I am a specialist thoracic oncologist and am an internationally recognised expert in the treatment of lung cancer, mesothelioma and cancers of the thymus (thymoma and thymic carcinoma).
I qualified from Guy’s and St Thomas’ Hospitals in 1994 with triple distinction and the Solly Medal, completed general medical training at the Royal Brompton and the Hammersmith Hospitals, and medical oncology training at The Royal Marsden. I was awarded a PhD in Molecular Genetics in 2002 and thereafter undertook a postdoctoral Clinician Scientist Fellowship, and subsequently a HEFCE Clinical Senior Lectureship in the fields of Cancer Genomics.
I have published extensively, including on key clinical trials that have changed practice and have authored UK and European clinical guidelines on the treatment of thoracic cancers. My research allows me to provide state of the art care. I have a particular interest in how cancer gene alterations predict cancer drug benefit, especially how to treat lung cancer in never smokers. I am a regular commentator on new treatment advances to fellow professionals and advocates.
I am involved in many professional organizations nationally and internationally. I chair the British Thoracic Oncology Group (BTOG) Steering Committee and am immediate past Chair of the UK NCRI Lung Group Advanced Diseases Sub-group. I am Cancer Divisional Co-Director of the NIHR-South London Clinical Research Network and am lead for cancer for the West London Genomic Medicine Centre. I was elected onto the Foundation Council of the European Thoracic Oncology Platform (ETOP) and am active in the European Organisation for Research and Treatment of Cancer (EORTC) Lung Group alongside the International Thymic Malignancy Interest Group (ITMIG). I support patient advocacy and am Research Advisor to the Ruth Strauss Foundation and Honorary Advisor to ALK Positive UK.
Areas of interest
Lung cancer; Lung cancer in never-smokers; Thymic cancers; Mesothelioma. Within these areas I also have a special interest in the development of novel anti-cancer drugs including targeted agents and immunotherapy.
Medical secretaries
- Hayley Marks
- The Royal Marsden Hospital Fulham Road London SW3 6JJ
- 020 7808 2132
- pp.lungchelsea@rmh.nhs.uk
- Royal Marsden Central Referral Information Line
- 020 7811 8111
- private.patients@rmh.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
The Royal Marsden Hospital (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)
-
20365
Follow-up out-patient consultation - remote - (5-50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
-
20355
Initial out-patient consultation - remote - (1-5)